Sachetta’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.7K Buy
757
+27
+4% +$3.56K 0.05% 145
2026
Q1
$102K Buy
730
+18
+3% +$2.52K 0.06% 140
2025
Q4
$87.5K Hold
712
0.05% 151
2025
Q3
$79.1K Buy
712
+329
+86% +$37.4K 0.03% 217
2025
Q2
$42.5K Sell
383
-296
-44% -$31.5K 0.02% 274
2025
Q1
$76.1K Sell
679
-6
-0.9% -$619 0.03% 219
2024
Q4
$63.3K Sell
685
-23
-3% -$2.07K 0.03% 239
2024
Q3
$59.4K Buy
708
+351
+98% +$26.8K 0.02% 252
2024
Q2
$27.9K Sell
357
-9
-2% -$601 0.01% 302
2024
Q1
$29.7K Hold
366
0.01% 278
2023
Q4
$29.7K Buy
+366
New +$28.5K 0.01% 278

Other funds holding GILD

Sachetta's GILD Position: Q2 2026 in Review

Sachetta increased its Gilead Sciences (GILD) stake by 3.7% in Q2 2026, buying an estimated $3.56K and bringing the position to 757 shares worth $95.7K. The position accounts for 0.05% of the portfolio, ranked #145.

Sachetta first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $102K in Q1 2026. 485 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sachetta held 757 shares of Gilead Sciences worth $95.7K as of Q2 2026.
  • Sachetta bought 27 Gilead Sciences shares in Q2 2026, an estimated $3.56K.
  • Gilead Sciences made up 0.05% of Sachetta's portfolio in Q2 2026, its #145 holding.
  • Sachetta first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's Gilead Sciences position peaked at $102K in Q1 2026.
  • 485 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.